The efficacy and safety of SARS-CoV-2 vaccines mRNA1273 and BNT162b2 might be complicated by rampant C-to-U RNA editing

被引:0
|
作者
Zhongzheng Bian
Ziqian Wu
Nan Liu
Xiao Jiang
机构
[1] The Affiliated Hospital of Qingdao University,Department of Emergency Medicine
[2] The Affiliated Hospital of Qingdao University,Department of Emergency Intensive Care Unit
来源
关键词
SARS-CoV-2; Vaccines; Synonymous codon usage; C-to-U RNA editing; Efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
The SARS-CoV-2 RNA vaccines are smartly designed to increase the synonymous codon usage by introducing multiple U-to-C mutations. This design would elevate the translation efficiency of vaccine RNAs. However, we found evidence to reason that the designed cytidines might be converted to uridines again by C-to-U RNA deamination in host cells. This C-to-U mechanism might be a main factor that affects the efficacy and safety of RNA vaccines.
引用
收藏
页码:361 / 365
页数:4
相关论文
共 50 条
  • [21] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
    Jaime S. Rosa Duque
    Xiwei Wang
    Daniel Leung
    Samuel M. S. Cheng
    Carolyn A. Cohen
    Xiaofeng Mu
    Asmaa Hachim
    Yanmei Zhang
    Sau Man Chan
    Sara Chaothai
    Kelvin K. H. Kwan
    Karl C. K. Chan
    John K. C. Li
    Leo L. H. Luk
    Leo C. H. Tsang
    Wilfred H. S. Wong
    Cheuk Hei Cheang
    Timothy K. Hung
    Jennifer H. Y. Lam
    Gilbert T. Chua
    Winnie W. Y. Tso
    Patrick Ip
    Masashi Mori
    Niloufar Kavian
    Wing Hang Leung
    Sophie Valkenburg
    Malik Peiris
    Wenwei Tu
    Yu Lung Lau
    Nature Communications, 13
  • [22] Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naive and Previously Infected Individuals: A Comparative Study
    Shurrab, Farah M.
    Al-Sadeq, Duaa W.
    Abou-Saleh, Haissam
    Al-Dewik, Nader
    Elsharafi, Amira E.
    Hamaydeh, Fatima M.
    Halawa, Bushra Y. Abo
    Jamaleddin, Tala M.
    Hameed, Huda M. Abdul
    Nizamuddin, Parveen B.
    Amanullah, Fathima Humaira
    Daas, Hanin I.
    Abu-Raddad, Laith J.
    Nasrallah, Gheyath K.
    VACCINES, 2022, 10 (02)
  • [23] Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period
    Wang, Lindsey
    Davis, Pamela B.
    Kaelber, David C.
    Volkow, Nora D.
    Xu, Rong
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07): : 678 - 680
  • [24] Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
    La Verde, Nicla
    Riva, Agostino
    Cona, Maria Silvia
    Gabrieli, Arianna
    Cattaneo, Monica
    Fasola, Cinzia
    Lipari, Giuseppe
    De Stradis, Claudia
    Favorito, Valentina
    Stocchetti, Benedetta Lombardi
    Chizzoniti, Davide
    Covizzi, Alice
    Rulli, Eliana
    Galli, Francesca
    Ruggieri, Lorenzo
    Gambaro, Anna
    Ferrario, Sabrina
    Dalu, Davide
    Tarkowski, Maciej S.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (04) : 661 - 671
  • [25] Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans
    Dickerman, Barbra A.
    Madenci, Arin L.
    Gerlovin, Hanna
    Kurgansky, Katherine E.
    Wise, Jessica K.
    Figueroa Muniz, Michael J.
    Ferolito, Brian R.
    Gagnon, David R.
    Gaziano, J. Michael
    Cho, Kelly
    Casas, Juan P.
    Hernan, Miguel A.
    JAMA INTERNAL MEDICINE, 2022, 182 (07) : 739 - 746
  • [26] Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients
    Mitchell, Jonathan
    Connolly, Caoilfhionn M.
    Chiang, Teresa Po-Yu
    Alejo, Jennifer L.
    Werbel, William A.
    Segev, Dorry L.
    Massie, Allan B.
    JAMA NETWORK OPEN, 2022, 5 (05)
  • [27] Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2
    Shimodaira, Yosuke
    Watanabe, Kenta
    Takahashi, So
    Koizumi, Shigeto
    Iijima, Katsunori
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (06) : E75 - E75
  • [28] Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
    Psichogiou, Mina
    Karabinis, Andreas
    Poulakou, Garyphallia
    Antoniadou, Anastasia
    Kotanidou, Anastasia
    Degiannis, Dimitrios
    Pavlopoulou, Ioanna D.
    Chaidaroglou, Antigoni
    Roussos, Sotirios
    Mastrogianni, Elpida
    Eliadi, Irene
    Basoulis, Dimitrios
    Petsios, Konstantinos
    Leontis, Konstantinos
    Kakalou, Eleni
    Protopapas, Konstantinos
    Jahaj, Edison
    Pratikaki, Maria
    Syrigos, Konstantinos N.
    Lagiou, Pagona
    Gogas, Helen
    Tsiodras, Sotirios
    Magiorkinis, Gkikas
    Paraskevis, Dimitrios
    Sypsa, Vana
    Hatzakis, Angelos
    VACCINES, 2021, 9 (09)
  • [29] Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine
    Dias, Leonor
    Soares-Dos-Reis, Ricardo
    Meira, Joao
    Ferrao, Diana
    Soares, Pedro Ribeirinho
    Pastor, Ana
    Gama, Guilherme
    Fonseca, Luisa
    Fagundes, Vitor
    Carvalho, Marta
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (08):
  • [30] Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure
    Schreckenberg, Rolf
    Woitasky, Nadine
    Itani, Nadja
    Czech, Laureen
    Ferdinandy, Peter
    Schulz, Rainer
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (03) : 345 - 361